Cloverfields Capital Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.64M | Buy |
37,714
+2,100
| +6% | +$147K | 0.78% | 55 |
|
|
2025
Q1 | $2.62M | Sell |
35,614
-119
| -0.3% | -$8.75K | 0.86% | 47 |
|
|
2024
Q4 | $2.34M | Buy |
35,733
+3,200
| +10% | +$210K | 0.75% | 48 |
|
|
2024
Q3 | $2.53M | Sell |
32,533
-5,501
| -14% | -$429K | 0.82% | 49 |
|
|
2024
Q2 | $2.97M | Buy |
38,034
+341
| +0.9% | +$26.6K | 1% | 45 |
|
|
2024
Q1 | $2.55M | Buy |
37,693
+425
| +1% | +$28.8K | 0.86% | 46 |
|
|
2023
Q4 | $2.51M | Buy |
37,268
+11,877
| +47% | +$800K | 0.98% | 43 |
|
|
2023
Q3 | $1.72M | Hold |
25,391
| – | – | 0.77% | 51 |
|
|
2023
Q2 | $1.82M | Buy |
25,391
+10,440
| +70% | +$747K | 0.59% | 51 |
|
|
2023
Q1 | $1.04M | Buy |
14,951
+6,907
| +86% | +$479K | 0.31% | 57 |
|
|
2022
Q4 | $545K | Hold |
8,044
| – | – | 0.17% | 52 |
|
|
2022
Q3 | $441K | Hold |
8,044
| – | – | 0.15% | 53 |
|
|
2022
Q2 | $531K | Sell |
8,044
-3,883
| -33% | -$256K | 0.16% | 50 |
|
|
2022
Q1 | $791K | Sell |
11,927
-1,318
| -10% | -$87.4K | 0.25% | 45 |
|
|
2021
Q4 | $772K | Hold |
13,245
| – | – | 0.24% | 47 |
|
|
2021
Q3 | $795K | Buy |
13,245
+62
| +0.5% | +$3.72K | 0.26% | 46 |
|
|
2021
Q2 | $790K | Buy |
13,183
+148
| +1% | +$8.87K | 0.23% | 45 |
|
|
2021
Q1 | $648K | Buy |
13,035
+276
| +2% | +$13.7K | 0.21% | 48 |
|
|
2020
Q4 | $638K | Buy |
+12,759
| New | +$638K | 0.24% | 45 |
|